Acamprosate กับการบำบัดรักษาโรคติดสุรา


  • Kanok Uttawichai Thanyarak Chiangmai Hospitol




Download data is not yet available.


1. Heyser BJMaCJ. Acamprosate: A prototypic neuromodulator in the treatment of alcohol
dependence. CNS Neurol Disord Drug Targets. 2010 March 9(1):23–32.

2. Susanne Rösner SL, Philippe Lehert, Michael Soyka. Acamprosate Supports Abstinence,
Naltrexone Prevents Excessive Drinking: Evidence From a Meta-Analysis With Unreported
Outcomes. J Psychopharmacol. 2008 22(1):11-23.

3. Administration SAaMHS. Medication and Counseling Treatment [updated 04/09/2020. Available

4. Medication-Assisted Treatment (MAT) 2013 [updated 10/28/2013. Available from:

5. J. L. Acamprosate in alcohol dependence: how does it work? Addiction. 1995;90:1179–88.

6. Durbin PH, T.; Chabac, S. , editor Pharmacodynamics and pharmacokinetics of acamprosate: An
overview. In: Soyka, M., editor. Acamprosate in Relapse Prevention of Alcoholism. 1st Campral
Symposium; 1995; Stuttgart, Germany: Springer.

7. Wilde MI WAA. A review of its pharmacology and clinical potential in the management of
alcohol dependence after detoxification. Drugs. 1997;53:1038–53.

8. Lovinger DM WG, Weight FF. Ethanol inhibits NMDA-activated ion current in hippocampal
neurons. Science. 1989;243:1721–4.

9. Spanagel R VV. New pharmacological treatment strategies for relapse prevention. Curr Top
Behav Neurosci. 2013;13:583–609.

10. Karl Mann FK, Rainer Spanagel, John Littleton. Acamprosate: Recent Findings and Future
Research Directions Alcoholism. 2008 July;32(7):1105-10.

11. Spanagel R KF. Drugs for relapse prevention of alcoholism: ten years of progress. Trends
Pharmacol Sci. 2008;29:109–15.

12. Bachteler D ED, Danysz W, Ciccocioppo R, Spanagel R. . The effects of acamprosate and
neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat.

13. Dahchour A DWP. Ethanol and amino acids in the central nervous system: assessment of the
pharmacological actions of acamprosate. Prog Neurobiol. 2000;60:343–62.

14. Kiefer F JH, Otte C, Demiralay C, Wolf K, Wiedemann K Increasing leptin precedes craving and
relapse during pharmacological abstinence maintenance treatment of alcoholism. J Psychiatr Res.
2005;39:545– 51.

15. Lemberger T PR, Dassesse D, Westphal M, Casanova E, Turiault M, Tronche F, Schiffmann SN,
Schütz G Expression of Cre recombinase in dopaminoceptive neurons. BMC Neurosci. 2007;8:4.

16. Bolo N NJ, Muzet M, De Witte P, Dahchour A, Durbin P, Macher JP. Central effects of
acamprosate: part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in
healthy young male volunteers. Psychiatry Res. 1998;82:115-27.

17. Mark A. Frye, David J. Hinton, Victor M. Karpyak, Joanna M. Biernacka, Lee J. Gunderson,
Scott E. Feeder, Doo-Sup Choi and John D. Port. Anterior cingulate glutamate is reduced by
acamprosate treatment in patients with alcohol dependence. Clin Psychopharmacol. 2016

18. Boeijinga PH PP, Soufflet L, Landron F, Danel T, Gendre I, Muzet M, Demazières A, Luthringer
R. Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent

19. Susanne Rösner AH-H, Stefan Leucht, Philippe Lehert, Simona Vecchi, Michael Soyka.
Acamprosate for alcohol dependence. Cochrane Database of Systematic Reviews 2010(9).






General Article